Ilan Shimon (I Shimon)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Peritoneal Dialysis

Prognostic Factors

Ejection Fraction

Top Venues

Clinical endocrinology

European journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Yaron Rudman, Hadar Duskin-Bitan, Hiba Masri-Iraqi, Amit Akirov, Ilan Shimon
Visual morbidity in macroprolactinoma: A retrospective cohort study. Clinical endocrinology (2024)
Yaron Rudman, Maria Fleseriu, Laura Dery, Hiba Masri-Iraqi, Liat Sasson, Tzipora Shochat, Shiri Kushnir, Ilan Shimon, Amit Akirov
Endogenous Cushing's syndrome and cancer risk. European journal of endocrinology 191 (2) (2024)
Yaron Rudman, Maria Fleseriu, Laura Dery, Hiba Masri-Iraqi, Liat Sasson, Tzipora Shochat, Shiri Kushnir, Ilan Shimon, Amit Akirov
Endogenous Cushing's syndrome and cancer risk. European journal of endocrinology 191 (2) (2024)
I Slutzky-Shraga, Dania Hirsch, A Gorshtein, H Masri-Iraqi, T Shochat, Eyal Robenshtok, Ilan Shimon, Gloria Tsvetov
Features of patients and fracture risk in hypoparathyroidism; a single center study. Journal of endocrinological investigation (2023)
Yaron Rudman, Hadar Duskin-Bitan, Hiba Masri-Iraqi, Amit Akirov, Ilan Shimon
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma. Pituitary 25 (6) (2022)
Tamar Eshkoli, Merav Fraenkel, Dana Zaid, Dayana Cohen, Uri Yoel, Gloria Tsvetov, Alexander Gorshtein, Adi Goldbart Nahmias, Yona Greenman, Ilan Shimon
Resistant prolactinomas: a case series of 26 patients. Endocrine 77 (2) (2022)
Yaron Rudman, Hadar Duskin-Bitan, Yossi Manisterski, Barak Pertzov, Amit Akirov, Hiba Masri-Iraqi, Ilan Shimon
Long-term response to cabergoline and multi-modal treatment in men with macroprolactinoma: Does size really matter? Clinical endocrinology 95 (4) (2021)
Ilan Shimon, Yaron Rudman, Yossi Manisterski, Alex Gorshtein, Hiba Masri, Hadar Duskin-Bitan
True hyperprolactinemia in men without visible pituitary adenoma. Endocrine 72 (3) (2021)
Hadar Duskin-Bitan, Ilan Shimon
Prolactinomas in males: any differences? Pituitary 23 (1) (2020)
Raquel Soares Jallad, Ilan Shimon, Merav Fraenkel, V Medvedovsky, Amit Akirov, Felipe Gaia Duarte, Marcello Delano Bronstein
Outcome of pregnancies in a large cohort of women with acromegaly. Clinical endocrinology 88 (6) (2018)
Ilan Shimon, Zaina Adnan, Alexander Gorshtein, Lior Baraf, Nariman Saba Khazen, Michal Gershinsky, Yulia Pauker, Ali Abid, Mark J Niven, Carmela Shechner, Yona Greenman
Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study. Endocrine 62 (2) (2018)
Ilan Shimon
Giant prolactinomas: Multi-modal approach to achieve tumor control. Endocrine 56 (2) (2017)
Amit Tirosh, Ilan Shimon
Complications of acromegaly: thyroid and colon. Pituitary 20 (1) (2017)